MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Jefferson Capital, Inc. (NASDAQ: JCAP) (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, announced today that it has amended and extended its senior secured revolving credit facility via a syndication led by Citizens Bank. Key components of the amendment include, among other items: An increase of the aggregate committed capital by $175,000,000 to $1,000,000,000A reduction of the i ...

Core Insights - CTS Corporation reported strong growth in the third quarter of 2025, with sales increasing by 22% year-over-year in diversified end markets, while overall sales rose by 8% to $143 million [2][7] - The company emphasized diversification as a strategic priority to enhance growth and margin expansion [2] - For 2025, CTS has narrowed its sales guidance to a range of $535-$545 million and adjusted diluted EPS to between $2.20 and $2.25, assuming current market conditions persist [3] Financial Performance - Net income for Q3 2025 was $14 million, representing 9.6% of sales, which included a $4.2 million charge related to an EPA claim [7] - Adjusted diluted EPS was $0.60, slightly down from $0.61 in Q3 2024, while diluted EPS decreased to $0.46 from $0.59 in the same period [7][25] - Adjusted gross margin improved to 38.9% from 38.2% year-over-year, while adjusted EBITDA margin decreased to 23.8% from 24.4% [7][23] Market Segments - Sales to diversified end markets, which include industrial, aerospace & defense, and medical sectors, saw a significant increase of 22% [7][8] - Conversely, sales to the transportation end market experienced a decline of 7% [7] Cash Flow and Expenses - Operating cash flow for Q3 2025 was reported at $29 million, down from $35 million in Q3 2024 [7] - The company incurred selling, general, and administrative expenses of $27.2 million, up from $22.5 million year-over-year [7][12] Balance Sheet Highlights - As of September 30, 2025, total assets were $790.4 million, an increase from $765.4 million at the end of 2024 [15] - Current assets rose to $276.2 million, compared to $242.2 million in the previous year [15] Future Outlook - CTS Corporation's management remains optimistic about the company's growth trajectory, driven by its focus on diversification and solid execution in challenging market conditions [2][3]

Out of 1,146 independent agencies nominated nationwide, only 348 achieved this prestigious honorAUGUSTA, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Provident Protection Plus, a full-service insurance agency that offers comprehensive insurance programs to protect businesses, their employees, and consumers, has announced that it has retained its Best Practices status for 2025, joining an elite group of independent insurance agencies for the second time in a row from across the U.S. The Best Practices Agency desi ...

SEATTLE, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Business Highlights Continued progress was made in processing Tau proteoform samples from collaborators in support of our goals of product validation and growing our publications. We expect to share this data at the upcoming World HUPO confer ...

To enhance and accelerate regulatory dialogue with the FDA To provide strategic guidance across clinical development programsTo bring deep expertise in CNS and immuno-oncology MADRID and CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, BME: ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, is pleased to announce the strategic collaboration with Dr. Iman Barilero, PharmD, PhD, as Senior Advisor for Regulatory Affairs to suppo ...

Core Viewpoint - NANO Nuclear Energy Inc. has rebranded its Canadian operations as True North Nuclear Inc. following the acquisition of Global First Power Limited, aiming to lead advanced nuclear modular microreactor development in North America [1][2][3] Company Developments - True North Nuclear will focus on constructing and seeking regulatory approval for the KRONOS MMR Energy System project in Canada, with plans to submit a License to Prepare Site to the Canadian Nuclear Safety Commission [3][4] - The company is also advancing pre-construction work for a KRONOS MMR research prototype at the University of Illinois Champaign-Urbana, with a construction permit application to the U.S. Nuclear Regulatory Commission planned for Q1 2026 [4][5] Strategic Goals - The rebranding reflects the company's commitment to innovation in nuclear energy and aims to position North America as a hub for next-generation nuclear technologies [3][5] - True North Nuclear is seen as a critical component of the company's strategy to lead advanced nuclear microreactor technologies across North America, leveraging Canada's supportive regulatory framework [5][6] Subsidiary Focus - NANO Nuclear operates several subsidiaries, including Advanced Fuel Transportation Inc., which aims to provide HALEU fuel to various sectors, and HALEU Energy Fuel Inc., focusing on domestic HALEU fuel fabrication [8][9] - NANO Nuclear Space Inc. is exploring commercial applications of micronuclear reactor technology for space missions, particularly focusing on cis-lunar applications [10]

UNIONDALE, NY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and consumer products company, today announced that it has engaged RedChip Companies (“RedChip”) to lead its investor relations efforts. “We are entering a transformative phase for ProPhase,” said Ted Karkus, CEO and Chairman of ProPhase Labs. “With the imminent commercialization of our BE-Smart™ esophageal cancer diagnostic, continued expansion of our Nebul ...

Strong Operational Performance Drives Revenue and Gross Profit GrowthSINGAPORE, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced its interim financial results for the six months ended June 30, 2025. Key Strategic Developments On February 12, 2025, the Company’s wholly owned subsidiary, Uni-Fuels Pte Ltd (“Uni-Fuels Singapore”), received ISCC EU and ISCC PLUS cert ...

Core Points - Boralex has appointed Ted Di Giorgio to its Board of Directors, enhancing the board's financial expertise and understanding of complex business environments [1][2] - Ted Di Giorgio brings nearly 35 years of experience from EY, advising various industries and serving on the Board of Directors and Audit Committee of Héroux-Devtek Inc. [3] - Boralex is a leader in renewable energy, with over 30 years of experience, and has increased its installed capacity by more than 50% to 3.2 GW over the past five years [4] Company Overview - Boralex is a prominent player in the renewable energy sector, particularly in Canada and France, focusing on onshore wind power and expanding into solar and storage projects [4] - The company is developing a portfolio of projects totaling 8.2 GW, guided by its corporate social responsibility values [4] - Boralex's shares are traded on the Toronto Stock Exchange under the ticker symbol BLX [4]

SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will participate in the below November investor conferences. Details are as follows: Event: Guggenheim 2nd Annual Healthcare Innovation ConferenceDate: November 11, 2025Time: 8:00 AM ETFormat: Fireside Chat Event: Jefferies London Healthcare Conference Date: November 1 ...